Anti-oncoprotein endostatin derivative
一种内皮抑素、抗肿瘤的技术,应用在抗肿瘤药、肽/蛋白质成分、动物/人类蛋白质等方向,能够解决不稳定、内皮抑素半衰期短、影响内皮抑素抗肿瘤治疗效果等问题,达到抗肿瘤生物活性高、半衰期长的效果
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] Example 1 A derivative of the anti-tumor protein endostatin, the derivative includes a fusion protein of endostatin linked to the constant region of antibody IgG, its anti-tumor activity and the half-life of the fusion protein in mice.
[0051] protein sample
[0052] Sample 1: pre-sequence-endostatin; the front of endostatin shown in SEQ ID NO.4 is connected with the pre-sequence shown in SEQ ID NO.2, and the signal peptide in the pre-sequence is to allow expressed endostatin can be secreted extracellularly.
[0053] Sample 2: fusion protein of pre-sequence-endostatin-antibody IgG partial constant region CH1 (shown in SEQ ID NO.8, the nucleic acid sequence encoding SEQ ID NO.8 is shown in SEQ ID NO.7).
[0054] Sample 3: pre-sequence-endostatin-antibody IgG partial constant region CH1CH2 fusion protein (shown in SEQ ID NO.10, the nucleic acid sequence encoding SEQ ID NO.10 is shown in SEQ ID NO.9).
[0055] Sample 4: pre-sequence-endostatin-antibody IgG constant regi...
Embodiment 2
[0062] Example 2 Evaluation of the newly introduced Arg in front of the N-terminus of endostatin derivatives
[0063] Select the pre-sequence-endostatin-antibody IgG constant region fusion protein (SEQ ID NO.11 and SEQ ID NO.12) of Example 4 of Example 1 as the experimental material, and illustrate it with the amino acid sequence (SEQ ID NO.12) , 1-23 amino acids are derived from albumin, 1-18 is the signal peptide of albumin, 19-23 are the 5 amino acids at the N-terminal of mature albumin, of which there are two Arg, 24-206 are endostatin, 207-536 is the constant region of antibody IgG, which consists of CH1, CH2 and CH3. Various experimental proteins:
[0064] Sample 1: fusion protein of pre-sequence-endostatin-antibody IgG constant region, represented by SEQ ID NO.12, wherein 19-23 are Arg-Gly-Val-Phe-Arg.
[0065] Sample 2: pre-sequence-endostatin-antibody IgG constant region fusion protein point mutant 1, in which 19-23 is Ala-Gly-Val-Phe-Arg, the agg point mutation of ...
Embodiment 3
[0072] Example 3 Checking the Effect of Glycosylation Sites on the Activity of Endostatin Fusion Protein
[0073] Using the pre-sequence-endostatin-antibody IgG constant region CH1CH2CH3 fusion protein (SEQ ID NO.11 and SEQ ID NO.12) of Example 1 as the experimental material to construct derivatives, that is, the N-terminal front of endostatin or A glycosylated amino acid short peptide Gly-Ala-Ser-Asn-Ser-Thr-Gly-Ala-Ser is added behind the C-terminus, where Asn-Ser-Thr is the position of glycosylation, and the sugar chain is connected to Asn. The plasmid (pHEK293) expressing the front sequence-endostatin-antibody IgG constant region CH1CH2CH3 fusion protein (shown in SEQ ID NO.12, encoding the nucleic acid sequence SEQ ID NO.11 of SEQ ID NO.12) in Example 1 was selected Ultra Expression Vector II) for various gene manipulations, and the gene fragments of these mutants can also be directly synthesized, and then inserted into the plasmid (pHEK293 Ultra Expression Vector II) to ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com